Placebo Effect Clinical Trial
Official title:
The Effect of Tablet Size on Cognitive Performance: A Randomized Control Trial Using Caffeine
This study aims to assess if tablet size, due to placebo effect, alters participants' performance on cognitive tests after consuming caffeine. Participants will be randomly assigned to one of four groups: 1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule.
Background: A capsule's physical design (e.g. shape, size, and color) affects individuals' perception of drug efficacy; that is, how well a drug is likely to work. The goal of this study is to assess the effects tablet size may have on participant's performance on cognitive testing since research has found differences between preparation methods. Method: 120 participants will be randomly assigned to one of four groups: 1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule. Participants will consume the designated placebo tablet with water (caffeinated or non-caffeinated); then, participants will provide weekly caffeine intake and complete the neutral portion of Velten's Mood Induction Procedure until 30 minutes have passed to allow for caffeine activation. Participants will complete the Stroop test, Trial Making Tests A and B, and the Rey Auditory Verbal Learning Test. Previous literature, as far as the author knows, relied on evaluating drug efficacy based on appearance alone. This study aims to assess if tablet size, due to placebo effect, alters participants' performance on cognitive tests after consuming caffeine. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04650841 -
The Role of the Opioid System in Placebo Effects on Pain and Social Rejection
|
Early Phase 1 | |
Not yet recruiting |
NCT04646460 -
Context Interventions: Social Modeling and Initial Treatment Experience
|
N/A | |
Completed |
NCT04571827 -
The Influence of Expectations on Post-needling Soreness and Pain Processing After Dry Needling Treatment
|
N/A | |
Completed |
NCT01501591 -
Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
|
N/A | |
Completed |
NCT02802241 -
Effects of Open-label vs Double-blind Treatment in IBS
|
N/A | |
Not yet recruiting |
NCT06423365 -
A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
|
N/A | |
Completed |
NCT03017534 -
Non-Specific Effects of Manual Therapy
|
N/A | |
Completed |
NCT02578420 -
Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo
|
N/A | |
Completed |
NCT02578212 -
Trust Game and Placebo Response
|
N/A | |
Completed |
NCT00426010 -
Measuring Placebo Effect by Elimination and Investigating Mechanism of Action
|
N/A | |
Completed |
NCT02365220 -
Smartphone Application, Mood and Stress
|
N/A | |
Completed |
NCT01501747 -
The Placebo Effect May Involve Modulating Drug Bioavailability
|
N/A | |
Recruiting |
NCT04766580 -
Attention and Pain in Children With and Without Attention Deficit and/or Hyperactivity Disorder
|
N/A | |
Completed |
NCT05004467 -
Clinical Predictive Effects of Mulligan Treatment in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT03950999 -
Experimental Pain Reporting Accuracy and Placebo Response
|
N/A |